Pharma-Biotech Third-Quarter 2015 Update: $6.4 Billion of Investments in Project Starts
Pharma-Biotech Third-Quarter 2015 Update: $6.4 Billion of Investments in Project Starts
Attachment: Pharma-Biotech Projects, July 2015
SUGAR LAND--July 14, 2015--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Within the next three months, the Pharmaceutical-Biotech Industry is expected to launch nearly $6.4 billion worth of North American capital and maintenance (MRO) projects. An analysis by Industrial Info's Pharmaceutical Tracker - Online Database of active capital and MRO projects shows that a 68% jump in spending--from third-quarter 2014's $3.8 billion.
Within this article: Details on key projects from major companies, such as Boehringer Ingelheim Vetmedica, Procter & Gamble (NYSE:PG) and Genzyme (NASDAQ:GENZ), as well as Northwestern University.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Tetra Tech at Work on More than $18.8 Billion in U.S. Projects
- Pharma-Bio Industry Capital Construction Monitor: Projects Underway in Nort...
- New Build Report: Pharmaceutical-Biotech Sector Plans 205 New Facilities wi...
- Great Lakes Region Springs into Second-Quarter 2015 with $1.5 Billion in Ne...
- Head of Class: Top 10 Higher-Ed Life Science Projects in 2015 Exceed $2.6 B...